Stay updated with the latest eli-lilly-and-company news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on eli-lilly-and-company topics.

New Delhi, April 3 (SocialNews.XYZ) Scientists have found that those living with obstructive sleep apnea (OSA) have a 71 per cent higher risk of cardiovascular events (CVEs) or death from any cause (all-cause mortality) compared with those not living with OSA. New research, to be presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, May 12-15), is a collaboration between Imperial College Health Partners; Imperial College Healthcare NHS Trust, London, UK; and Eli Lilly and C ...Read More >

April 1 (Reuters) - U.S. stock futures advanced on Wednesday, after the indexes saw their biggest one-day gains in nearly a year in the previous session, following President Donald Trump's comments that suggested a swift end to the Middle East conflict. Trump and Secretary of State Marco Rubio said on Tuesday that the end of the Iran war could be near, signaling potential for both direct talks with Iranian leadership and a winding down of the conflict without a deal. Trump is scheduled to addre ...Read More >

By Johann M Cherian and Shashwat Chauhan Dec 16 (Reuters) - U.S. stock index futures were slightly lower on Tuesday as caution set in ahead of a highly anticipated jobs report that could offer insight into the health of the economy and the potential path for interest rates next year. A recent historic government shutdown left investors and the Federal Reserve starved of official data and increasingly reliant on secondary indicators that offered a mixed picture on the health of the labor m ...Read More >

While India continues to attract record levels of foreign investment and corporate expansion, Pakistan has witnessed a steady retreat of global firms... While India continues to attract record levels of foreign investment and corporate expansion, Pakistan has witnessed a steady retreat of global firms across sectors. This contrast reflects not only macroeconomic trends but also the underlying business culture, regulatory frameworks, and institutional capacity that shape investor confidence and ...Read More >
(Reuters) -Eli Lilly will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, as it seeks to tap into skilled workforce to bolster its global manufacturing expansion. The collaborations aim to increase the availability of Lilly's key drugs, including those for obesity, diabetes, Alzheimer's, cancer and autoimmune conditions, the company said. "We are making significant investments to increase manufactu ...Read More >

Mumbai: Less than a month after Ozempic maker Novo Nordisk announced it is cutting its global workforce as part of a restructuring plan, the layoffs have hit Indian employees in Bengaluru. Junior- to mid-level employees across functions such as sales and marketing, as well as those in the company's global business services (GBS) hub, which works with its global teams, have been impacted, according to at least three people aware of the development. "At least 100-150 will be retrenched from the ...Read More >

New Delhi [India], September 26 (ANI): European countries are expected to face the most immediate and severe impact from the new U.S. tariffs on imported branded or patented pharmaceutical products, while India may remain less affected for now, according to a press release by the Global Trade Research Initiative (GTRI). On Friday, U.S. President Donald Trump announced that from October 1, a 100 per cent tariff would be imposed on all imported branded or patented pharmaceutical products, unless ...Read More >

MUMBAI, Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to bring its experimental oral weight-loss drug orforglipron to India as it sees market potential in the world's most populous nation, a senior executive said on Thursday. "I do think there is promise for products like that (orforpligron) in India, if it does get approved," Winselow Tucker, Lilly India's president said at an event in Mumbai. Tucker, however, did not indicate when Lilly plans to launch the drug. The drugmaker h ...Read More >
STORY: Wall Street hit a milestone on Tuesday as all three major stock indexes closed at record highs, with the Dow adding more than four-tenths of a percent, the S&P 500 gaining over a quarter of a percent and the Nasdaq climbing more than a third of a percent. Data released on Tuesday showed U.S. employers added nearly a million fewer jobs in the 12 months through March than previously estimated. The large downward revision supported expectations the Federal Reserve will soon cut interest ra ...Read More >

New Delhi [India], July 16 (ANI): The Indian government expressed regret on Tuesday over the reported demolition of the ancestral property of celebrated filmmaker and writer Satyajit Ray in Mymensingh, Bangladesh and expressed its willingness to extend cooperation in its restoration. "We note with profound regret that the ancestral property of noted filmmaker and litterateur Satyajit Ray in Mymensingh, Bangladesh, belonging to his grandfather and eminent litterateur, Upendra Kishor Ray Chowdhur ...Read More >

India Diabetes Market: By Type; By Treatment Type; By Doses Form; Route of Administration; By End User; By Distribution Channel; Supplier Landscape; 2025-2034 The India diabetes market attained a value of approximately INR 316.00 Billion in 2024. The market is projected to grow at a compound annual growth rate (CAGR) of 16.00% during the forecast period of 2025-2034, reaching an estimated value of around INR 1394.01 Billion by 2034. The rising prevalence of diabetes, driven by sedentary lifesty ...Read More >

New Delhi [India], June 27 (ANI): Congress MP Manickam Tagore launched a scathing attack on the Rashtriya Swayamsevak Sangh (RSS) on Friday following remarks by its General Secretary Dattatreya Hosabale, who questioned the legitimacy of including the terms "socialist" and "secular" in the Preamble of the Indian Constitution. Reacting to Hosabale's statement that these terms were "forcibly inserted" during the Emergency and should now be reconsidered, Tagore took to social media platform X to is ...Read More >

Ahmedabad (Gujarat) [India], June 27 (ANI): Union Home Minister Amit Shah on Friday offered prayers at the over 400-year-old Jagannath Temple in Ahmedabad on the occasion of Rath Yatra. He offered the "mangala aarti" at 4 am and shared a heartfelt post on his official "X" account, reflecting on his divine experience. Also Read | Mounjaro KwikPen: Eli Lilly and Company's Type 2 Diabetes and Obesity Drug Gets Approval in India, To Compete With Novo's Weight-Loss Drug Wegovy. "On the sacred occa ...Read More >

Chandigarh, Jun 27 (PTI) The mother of jailed gangster Jaggu Bhagwanpuria and another person accompanying her died after being shot at by unidentified bike-borne people in Punjab's Batala, police said on Friday. Harjit Kaur was critically injured after the incident on Thursday late evening and was referred to a hospital in Amritsar, but she succumbed to the bullet injuries, a senior police official from Batala said over the phone. Also Read | Mounjaro KwikPen: Eli Lilly and Company's Type 2 Di ...Read More >
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular weight-loss drug Wegovy over fears of falling behind rival Eli Lilly in the potentially huge market, two sources familiar with the plans told Reuters. Officials at the Danish drugmaker have said Wegovy might be introduced in India in 2026 once regulatory approvals are in hand and there is sufficient supply. More recently, Novo's India team proposed moving the launch to nex ...Read More >
AstraZeneca is benefiting from surging demand for cancer treatments like Imfinzi and Calquence, and has a robust pipeline expected to deliver two dozen new products by 2030. Leading vaccine makers like Eli Lilly (NYSE:LLY), Pfizer (NYSE:PFE), and AstraZeneca NASDAQ:AZN) may have faded from the spotlight since the peak of the COVID-19 pandemic, but now there is reason to expect renewed interest. As investors look ahead to the second Trump administration, the incoming president's nomination of ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.